Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.5051
Nov 19 • 11:52 AM ET Dollar change-0.0056 Percentage change(-1.10%)
Index
-
Market Cap
13.87M
Enterprise Value
13.34M
Income
-46.27M
Sales
7.11M
Book/sh
2.43
Cash/sh
0.62
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
23
IPO
Oct 02, 2014
P/E
-
Forward P/E
-
PEG
-
P/S
1.95
P/B
0.21
P/C
0.82
P/FCF
-
EV/EBITDA
-
EV/Sales
1.88
Quick Ratio
0.40
Current Ratio
0.84
Debt/Eq
0.11
LT Debt/Eq
0.11
Option/Short
Yes / Yes
EPS (ttm)
-2.11
EPS next Y
-1.44
EPS next Q
-0.41
EPS this Y
39.94%
EPS next Y
29.06%
EPS next 5Y
41.69%
EPS past 3/5Y
16.24% 21.29%
Sales past 3/5Y
- -
EPS Y/Y TTM
57.48%
Sales Y/Y TTM
-
EPS Q/Q
57.59%
Sales Q/Q
-
Insider Own
1.80%
Insider Trans
0.00%
Inst Own
4.61%
Inst Trans
-2.33%
ROA
-34.29%
ROE
-70.29%
ROIC
-62.86%
Gross Margin
19.97%
Oper. Margin
-863.92%
Profit Margin
-651.27%
SMA20
-2.86%
SMA50
-2.55%
SMA200
-20.78%
Trades
Shs Outstand
27.45M
Shs Float
26.96M
52W High
1.54 -67.20%
52W Low
0.37 36.55%
Volatility
11.36% 12.98%
ATR (14)
0.05
RSI (14)
47.97
Beta
1.02
Rel Volume
0.44
Avg Volume
312.50K
Volume
55,599
Perf Week
-5.13%
Perf Month
27.71%
Perf Quarter
-15.84%
Perf Half Y
-24.96%
Perf YTD
-34.99%
Perf Year
-49.49%
Perf 3Y
-97.39%
Perf 5Y
-98.82%
Perf 10Y
-99.73%
Prev Close
0.51
Price
0.51
Change %
-1.10%
Consensus
Strong Buy
Avg. Price Target
$4.00
Implied Upside
+691.9%
Analysts2incl. previous ratings
Rating Distribution2 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Dec 30, 2024Upgrade
DD. Boral Capital
Hold → Buy$9+1,681.8%
Nov 30, 2021Initiated
MMaxim Group
Buy$4+691.9%
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone, Leonard Mazur, Myron Holubiak on January 23, 2007 and is headquartered in Cranford, NJ.
Co-FounderMr. Leonard L. Mazur
Co-Founder & Executive Vice ChairmanMr. Myron Z. Holubiak
Executive VP & Chief Medical OfficerDr. Myron S. Czuczman M.D.
Chief Business Officer & CFOMr. Jaime Bartushak
Executive Vice President of OperationsMr. Gary F. Talarico